Skip to main content
Home
FULL MENU Close Menu
Home
Home

Neil Osterweil

News

ACE inhibitor prevents trastuzumab-associated LVEF decline after anthracyclines in BC treatment

Author:
Neil Osterweil
Publish date: June 7, 2021

The rate of left ventricular ejection fraction declines below 50% in patients on anthracyclines and trastuzumab...

  • Read More

News

Pregnancy effect on chemotherapy does not affect maternal breast cancer outcomes

Author:
Neil Osterweil
Publish date: June 7, 2021

There were no significant differences in survival outcomes between pregnant women with breast cancer and...

  • Read More

News

Collaborative effort reduces COPD readmissions, costs

Author:
Neil Osterweil
Publish date: June 6, 2021

A joint performance-improvement initiative helped reduce COPD-related ED visits and readmissions within 30 days...

  • Read More

News

IL-6 levels predict distant breast cancer recurrence

Author:
Neil Osterweil
Publish date: June 4, 2021

If validated in further studies, IL-6 levels could be a biomarker for response to therapies targeting...

  • Read More

News

Venetoclax shows activity against T-ALL in children

Author:
Neil Osterweil
Publish date: June 1, 2021

Patients with T-lineage acute lymphoblastic leukemia (4/7) in a small retrospective study had complete responses...

  • Read More

News

COPD in younger adults deadlier than expected

Author:
Neil Osterweil
Publish date: May 25, 2021

The mortality rate for younger adults with COPD was five times higher than that of their peers without COPD....

  • Read More

News

Patients with moderate COPD also benefit from triple therapy

Author:
Neil Osterweil
Publish date: May 25, 2021

The benefits of triple-therapy seen in the ETHOS trial were not limited to patients with severe COPD, a subanalysis shows.

  • Read More

News

Sex differences in COPD symptoms predict cardiac comorbidity

Author:
Neil Osterweil
Publish date: May 19, 2021

“Our findings give hints how diagnostic information might be used differently in men and women.”

  • Read More

News

Worse outcomes for patients with COPD and COVID-19

Author:
Neil Osterweil
Publish date: May 19, 2021

Worse outcomes include 14-day hospitalization, length of stay, ICU admission, 30-day mortality, and use of...

  • Read More

News

Sex differences in pediatric B-ALL outcomes persist

Author:
Neil Osterweil
Publish date: May 19, 2021

Boys with B-lineage acute lymphoblastic leukemia continue to have slightly worse survival outcomes than girls...

  • Read More

News

Dr. Fauci: Extraordinary challenges, scientific triumphs with COVID-19

Author:
Neil Osterweil
Publish date: May 18, 2021

“The speed and efficiency with which these highly efficacious vaccines were developed, and their potential for...

  • Read More

News

New guideline provides recommendations on reconstruction after skin cancer resection

Author:
Neil Osterweil
Publish date: May 13, 2021

The multidisciplinary consensus guideline covers situations broadly applicable to the care of adults with fully resected skin cancer lesions.

  • Read More

News

Pediatric cancer survivors at risk for opioid misuse

Author:
Neil Osterweil
Publish date: May 5, 2021

In the first year after the end of treatment, survivors of childhood cancers were at significantly greater risk...

  • Read More

News

No SPARKLE with ibrutinib plus chemo in r/r pediatric B-NHL

Author:
Neil Osterweil
Publish date: May 5, 2021

Patients assigned to ibrutinib and chemotherapy had a higher proportion of prior rituximab exposure, a marker...

  • Read More

News

High MRD rates with CAR T in r/r B-ALL in kids

Author:
Neil Osterweil
Publish date: May 4, 2021

Of 24 patients with relapsed/refractory disease, 16 went on to allogeneic stem cell transplant after responding to therapy with KTE-X19.

  • Read More

Pages

  • « first
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • last »

Privacy Policy

Terms of Use

Editorial Policy

Cookie Policy

Ad Policy

Medscape Customer Support

Frequently Asked Questions

 

Advertise with MDedge

See more with MDedge! See our Other Publications

MDedge: Keeping You Informed. Saving You Time.

Copyright  © 2022 Frontline Medical Communications Inc., Newark, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Close